Recognize lipedema federally
Petitioners ask the Government of Canada to formally recognize lipedema, include it in the National Women’s Health Strategy (Bill S‑243), and support national clinical guidance, education, data collection and coordinated federal–provincial action.
Why we would sign this petition
- Federal recognition would enable national clinical guidance and standardized care, helping clinicians diagnose lipedema earlier and improving patient access to treatment.
- Including lipedema in the National Women’s Health Strategy would focus federal attention on research, education and data collection for a condition affecting many women.
- Coordinated federal–provincial action can reduce regional disparities, support clinician training and strengthen patient support networks across jurisdictions.
Why we wouldn’t sign this petition
- Health care delivery is principally provincial; federal recognition could raise jurisdictional conflicts and require complex federal–provincial negotiations.
- Federal attention and funding are limited; prioritizing lipedema might divert resources from other established health needs.
- Provincial initiatives or targeted programs might be more practical or avoid duplication of effort compared with a new federal‑led approach.
The summary and both sets of reasons are AI-generated from the petition and given equal weight. Claims are the petitioners’ own; consult the official record for the full text.
Official petition
Petition to the House of Commons in Parliament assembled Lipedema is a chronic, progressive adipose and connective tissue disease that almost exclusively affects women; An estimated 2.2 million women in Canada are living with lipedema, many without diagnosis, treatment, or clinical support; Systemic gaps in Canada’s healthcare system have resulted in limited physician education, lack of diagnostic pathways, and absence of standardized care for people living with lipedema; The lack of recognition and resourcing for lipedema represents a significant inequity in healthcare; Bill S-243, An Act to Establish a National Strategy for Women’s Health, highlights the federal government’s role in addressing systemic inequities in women’s health and ensuring accountability at the national level; and While the Province of Manitoba has committed to establishing a provincial Lipedema Awareness Day beginning in 2026, there remains no federal recognition of lipedema or coordinated national response. We, the undersigned, residents of Canada,, call upon the Government of Canada to - Formally recognize lipedema as a distinct and serious women’s health condition at the federal level; - Include lipedema within the scope of the National Women’s Health Strategy contemplated under Bill S-243; - Support the development of national clinical guidance, education, and data collection related to lipedema; - Work collaboratively with provinces, territories, clinicians, and patient organizations, including Lipedema Canada, to address the systemic gaps in diagnosis, care, and support for people living with lipedema; and - Take all necessary measures to give effect to these requests.
Government response
No government response is available yet.